{"database": "openregs", "table": "documents", "rows": [["FDA-2021-N-1326-1539", "FDA", "FDA-2021-N-1326", "Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox; Public Hearing; Request for Comments; Extension of Comment Period", "Proposed Rule", "Extension of Comment Period", "2022-03-31T04:00:00Z", 2022, 3, "2022-03-31T04:00:00Z", null, "2022-03-31T12:50:05Z", "2022-06762", 0, 0, "0900006484fefb12"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2021-N-1326-1539"], "units": {}, "query_ms": 9.252645017113537, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}